Clinical Trial Update: To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial assessing the efficacy of CVN424 in Parkinson disease patients with motor complications is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• CVN424 (CVN424)

Snippet

Sponsor: Cerevance | Conditions: Parkinson Disease | Phase 3 | Status: ACTIVE_NOT_RECRUITING